Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-07

Clinical Trial Update: Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on polyethylene glycol for intestinal inflammation in cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyethylene Glycol (polyethylene glycol)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Cystic Fibrosis | Phase 2 | Status: UNKNOWN